Goldman Sachs
CMD

Goldman Sachs’s Cantel Medical Corporation CMD Stock Holding History

Goldman Sachs’s Portfolio CMD Stock Details CMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-30,000
Closed -$2.83M – 6791
2017
Q3 		$2.83M Buy
+30,000
New +$2.37M ﹤0.01% 3672

Goldman Sachs's CMD Position: Q2 2021 in Review

Goldman Sachs sold out of Cantel Medical Corporation (CMD) in Q2 2021, closing a stake of 612,388 shares — an estimated $48.9M sold.

Goldman Sachs first reported a position in CMD in Q2 2013 and held it in 32 quarters. The position peaked at $48.9M in Q1 2021. 0 funds tracked by Wall St. Rank hold CMD as of Q2 2021.

  • Goldman Sachs reported no remaining Cantel Medical Corporation position as of Q2 2021 after selling out during the quarter.
  • Goldman Sachs sold 612,388 Cantel Medical Corporation shares in Q2 2021, an estimated $48.9M.
  • Goldman Sachs first reported a position in Cantel Medical Corporation in Q2 2013 and held it in 32 quarters.
  • Goldman Sachs's Cantel Medical Corporation position peaked at $48.9M in Q1 2021.
  • 0 funds tracked by Wall St. Rank held Cantel Medical Corporation as of Q2 2021.

Based on Goldman Sachs's 13F filing for Q2 2021, filed 13 Aug 2021.